258 related articles for article (PubMed ID: 32563531)
21. Risk of second primary malignancy in patients with sinonasal tumors: a population-based cohort study.
Ganti A; Plitt MA; Kuan EC; Kuhar HN; Batra PS; Tajudeen BA
Int Forum Allergy Rhinol; 2018 Jun; 8(6):756-762. PubMed ID: 29381260
[TBL] [Abstract][Full Text] [Related]
22. Second Primary Malignancies in Patients with Colorectal Cancer: A Population-Based Analysis.
Jia H; Li Q; Yuan J; Sun X; Wu Z
Oncologist; 2020 Apr; 25(4):e644-e650. PubMed ID: 31943509
[TBL] [Abstract][Full Text] [Related]
23. Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer.
Galper S; Gelman R; Recht A; Silver B; Kohli A; Wong JS; Van Buren T; Baldini EH; Harris JR
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):406-14. PubMed ID: 11872286
[TBL] [Abstract][Full Text] [Related]
24. A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations.
Brown AP; Neeley ES; Werner T; Soisson AP; Burt RW; Gaffney DK
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):127-35. PubMed ID: 19910129
[TBL] [Abstract][Full Text] [Related]
25. Trends in the Risks of Secondary Cancers in Patients With Hodgkin Lymphoma.
Kumar V; Garg M; Chandra AB; Mayorga VS; Ahmed S; Ailawadhi S
Clin Lymphoma Myeloma Leuk; 2018 Sep; 18(9):576-589.e1. PubMed ID: 29934060
[TBL] [Abstract][Full Text] [Related]
26. Mortality patterns of patients with tonsillar squamous cell carcinoma: a population-based study.
Wang J; Li X; Niu D; Huang J; Ye E; Zhao Y; Yue S; Hou X; Wu J
Front Endocrinol (Lausanne); 2023; 14():1158593. PubMed ID: 38130394
[TBL] [Abstract][Full Text] [Related]
27. Atypical carcinoid tumor of the lung: a surveillance, epidemiology, and end results database analysis.
Steuer CE; Behera M; Kim S; Chen Z; Saba NF; Pillai RN; Owonikoko TK; Khuri FR; Ramalingam SS
J Thorac Oncol; 2015 Mar; 10(3):479-85. PubMed ID: 25371080
[TBL] [Abstract][Full Text] [Related]
28. Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008.
Donin N; Filson C; Drakaki A; Tan HJ; Castillo A; Kwan L; Litwin M; Chamie K
Cancer; 2016 Oct; 122(19):3075-86. PubMed ID: 27377470
[TBL] [Abstract][Full Text] [Related]
29. Risk of mortality and second malignancies in primary myelofibrosis before and after ruxolitinib approval.
Thomas JW; Jamy O; Shah MV; Vachhani P; Go RS; Goyal G
Leuk Res; 2022 Jan; 112():106770. PubMed ID: 34920340
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological features, risk and survival in lung cancer survivors with therapy-related acute myeloid leukaemia.
Wang H; Yin Y; Wang R; Huang J; Xue H; Cheng Y; Zhang L; Chen C
BMC Cancer; 2020 Nov; 20(1):1081. PubMed ID: 33172389
[TBL] [Abstract][Full Text] [Related]
31. Survival disparities for second primary malignancies diagnosed among childhood cancer survivors: A population-based assessment.
Brown AL; Arroyo VM; Agrusa JE; Scheurer ME; Gramatges MM; Lupo PJ
Cancer; 2019 Oct; 125(20):3623-3630. PubMed ID: 31251393
[TBL] [Abstract][Full Text] [Related]
32. Incidence of Second Primary Malignancies Following Colorectal Cancer: A Distinct Pattern of Occurrence Between Colon and Rectal Cancers and Association of Co-Morbidity with Second Primary Malignancies in a Population-Based Cohort of 98,876 Patients in Taiwan.
Lee YT; Liu CJ; Hu YW; Teng CJ; Tzeng CH; Yeh CM; Chen TJ; Lin JK; Lin CC; Lan YT; Wang HS; Yang SH; Jiang JK; Chen WS; Lin TC; Chang SC; Chen MH; Teng HW; Liu JH; Yen CC
Medicine (Baltimore); 2015 Jul; 94(26):e1079. PubMed ID: 26131831
[TBL] [Abstract][Full Text] [Related]
33. Second primary malignancies after ovarian cancer: A SEER-based analysis (1975-2016).
Yang Z; Liu X; Yang X; Liao QP
Taiwan J Obstet Gynecol; 2022 Jan; 61(1):80-85. PubMed ID: 35181052
[TBL] [Abstract][Full Text] [Related]
34. Incidence of second primary malignancies in metastatic castration-resistant prostate cancer: results from observational studies in three countries.
Vassilev ZP; Gabarró MS; Kaye JA; Saltus CW; Riedel O; Scholle O; Mehtälä J; Korhonen P; Garbe E; Zong J
Future Oncol; 2020 Sep; 16(25):1889-1901. PubMed ID: 32515225
[No Abstract] [Full Text] [Related]
35. Second Primary Malignancies following a Diagnosis of Conjunctival Melanoma.
Mahjoub H; Loya A; Ayaz T; Weng CY
Curr Eye Res; 2022 Apr; 47(4):634-641. PubMed ID: 34898336
[TBL] [Abstract][Full Text] [Related]
36. The risk of second primary malignancy in patients with stage Ia non-small cell lung cancer: a U.S. population-based study.
Khanal A; Lashari BH; Kruthiventi S; Arjyal L; Bista A; Rimal P; Uprety D
Acta Oncol; 2018 Feb; 57(2):239-243. PubMed ID: 29057703
[TBL] [Abstract][Full Text] [Related]
37. Exploring the risk of second primary malignancies in laryngeal cancer survivors: insights from the SEER database.
Afify AY; Ashry MH
Eur Arch Otorhinolaryngol; 2024 May; ():. PubMed ID: 38775833
[TBL] [Abstract][Full Text] [Related]
38. Risk and prognosis of secondary lung cancer after radiation therapy for thoracic malignancies.
Chen K; Liu C; Li X; Chen T; Liu S; Xiong F; Zhang Z
Clin Respir J; 2024 May; 18(5):e13760. PubMed ID: 38725324
[TBL] [Abstract][Full Text] [Related]
39. Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis.
Goyal A; O'Leary D; Goyal K; Rubin N; Bohjanen K; Hordinsky M; Chen ST; Pongas G; Duncan LM; Lazaryan A
J Am Acad Dermatol; 2020 Aug; 83(2):404-411. PubMed ID: 31374302
[TBL] [Abstract][Full Text] [Related]
40. Influence factors of the survival in colorectal cancer patients with second primary malignancy after surgery: A SEER database analysis.
Liu L; Chen B
Medicine (Baltimore); 2023 Oct; 102(40):e35286. PubMed ID: 37800769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
